Clinical Trial Update: Heme Arginate in Cardiac Surgery Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Heme Arginate in cardiac surgery patients with acute kidney injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Heme Arginate (heme arginate)

Snippet

Sponsor: University of Edinburgh | Conditions: Acute Kidney Injury | Phase 2 | Status: COMPLETED